VIP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Etoposide-Ifosfamide-Cisplatin Regimen; VePesid-Ifosfamide-Platinol Regimen; VIP; VIP Regimen; VP16-Ifosfamide-Platinol Regimen
Overview
Overview
VIP regimen refers to a regimen consisting of etoposide (vepesid), ifosfamide and cisplatin (platinol) used for the treatment of advanced-stage germ cell gonadal cancers[1] and Thymoma.[2]
Regimen
Regimen
VVePesid (etoposide)
IIfosfamide
PPlatinol (cisplatin)
References
References
- ↑ 1.0 1.1 Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ (1998). “Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study”. J Clin Oncol. 16 (4): 1287–93. PMID 9552027.
- ↑ 2.0 2.1 Loehrer PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas CR; et al. (2001). “Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial”. Cancer. 91 (11): 2010–5. PMID 11391579.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH